ScopeBiosciences

Revolutionising diagnostics trough CRISPR-Cas

[iGEM Community @iGEMCommunity]

We are excited to share that @Scope_Bio, led by iGEMers from the 2017 @igemwageningen, team has raised €1M funding!

Congratulations to the whole team and the CEO @SavelkoulNiek, who was also our 2019 iGEM Ambassador for Europe.

#AfteriGEM
https://t.co/P7JXczF4vK

[GenScript @GenScript]

Type III #CRISPR-Cas systems include recognition of target #RNA and subsequent induction of a multifaceted #immuneresponse, incorporating sequence-specific cleavage of target RNA and production of cyclic oligoadenylate molecules.

Read more @Nature: https://t.co/y88j5AA0sP

[Laboratory of Microbiology at WUR @MIB_WUR]

New fundamental insights on type III CRISPR-Cas systems resulting in a highly-sensitive diagnostic tool: SCOPE!

read it here: https://t.co/AXUQKxSq1s

By Jurre Steen, Yifan Zhu, Stijn Prinsen, John van der Oost, Raymond Staals and many others.

@Scope_Bio